BIG
MIRM icon

Brookwood Investment Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Brookwood Investment Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Hold
3,100
– – 0.04% 365
2026
Q1 		$286K Hold
3,100
– – 0.04% 405
2025
Q4 		$245K Hold
3,100
– – 0.03% 437
2025
Q3 		$227K Buy
+3,100
New +$197K 0.03% 425

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brookwood Investment Group's MIRM Position: Q2 2026 in Review

Brookwood Investment Group held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 3,100 shares worth $363K. The position accounts for 0.04% of the portfolio, ranked #365.

Brookwood Investment Group first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Brookwood Investment Group held 3,100 shares of Mirum Pharmaceuticals worth $363K as of Q2 2026.
  • Brookwood Investment Group left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up 0.04% of Brookwood Investment Group's portfolio in Q2 2026, its #365 holding.
  • Brookwood Investment Group first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.